120 related articles for article (PubMed ID: 16845889)
1. Mechanisms linking diabetes mellitus to the development of atherosclerosis: a role for endoplasmic reticulum stress and glycogen synthase kinase-3.
Robertson LA; Kim AJ; Werstuck GH
Can J Physiol Pharmacol; 2006 Jan; 84(1):39-48. PubMed ID: 16845889
[TBL] [Abstract][Full Text] [Related]
2. Glucosamine-induced endoplasmic reticulum dysfunction is associated with accelerated atherosclerosis in a hyperglycemic mouse model.
Werstuck GH; Khan MI; Femia G; Kim AJ; Tedesco V; Trigatti B; Shi Y
Diabetes; 2006 Jan; 55(1):93-101. PubMed ID: 16380481
[TBL] [Abstract][Full Text] [Related]
3. The Role of Endoplasmic Reticulum Stress-Glycogen Synthase Kinase-3 Signaling in Atherogenesis.
Huang A; Patel S; McAlpine CS; Werstuck GH
Int J Mol Sci; 2018 May; 19(6):. PubMed ID: 29848965
[TBL] [Abstract][Full Text] [Related]
4. Valproate protects cells from ER stress-induced lipid accumulation and apoptosis by inhibiting glycogen synthase kinase-3.
Kim AJ; Shi Y; Austin RC; Werstuck GH
J Cell Sci; 2005 Jan; 118(Pt 1):89-99. PubMed ID: 15585578
[TBL] [Abstract][Full Text] [Related]
5. Endoplasmic reticulum stress and glycogen synthase kinase-3β activation in apolipoprotein E-deficient mouse models of accelerated atherosclerosis.
McAlpine CS; Bowes AJ; Khan MI; Shi Y; Werstuck GH
Arterioscler Thromb Vasc Biol; 2012 Jan; 32(1):82-91. PubMed ID: 21998135
[TBL] [Abstract][Full Text] [Related]
6. Glucose-induced endoplasmic reticulum stress is independent of oxidative stress: A mechanistic explanation for the failure of antioxidant therapy in diabetes.
Mooradian AD; Haas MJ
Free Radic Biol Med; 2011 May; 50(9):1140-3. PubMed ID: 21320588
[TBL] [Abstract][Full Text] [Related]
7. [A new target for diabetes therapy: advances in the research of glycogen synthase kinase-3 inhibitors].
Liu SN; Shen ZF
Yao Xue Xue Bao; 2007 Dec; 42(12):1227-31. PubMed ID: 18338632
[TBL] [Abstract][Full Text] [Related]
8. Biochemistry and molecular cell biology of diabetic complications.
Brownlee M
Nature; 2001 Dec; 414(6865):813-20. PubMed ID: 11742414
[TBL] [Abstract][Full Text] [Related]
9. Mitochondrial malfunction and Ca2+ dyshomeostasis drive neuronal pathology in diabetes.
Verkhratsky A; Fernyhough P
Cell Calcium; 2008 Jul; 44(1):112-22. PubMed ID: 18191198
[TBL] [Abstract][Full Text] [Related]
10. Glycogen synthase kinase-3 (GSK-3) inhibitors reach the clinic.
Medina M; Castro A
Curr Opin Drug Discov Devel; 2008 Jul; 11(4):533-43. PubMed ID: 18600569
[TBL] [Abstract][Full Text] [Related]
11. Valproate attenuates accelerated atherosclerosis in hyperglycemic apoE-deficient mice: evidence in support of a role for endoplasmic reticulum stress and glycogen synthase kinase-3 in lesion development and hepatic steatosis.
Bowes AJ; Khan MI; Shi Y; Robertson L; Werstuck GH
Am J Pathol; 2009 Jan; 174(1):330-42. PubMed ID: 19095952
[TBL] [Abstract][Full Text] [Related]
12. Preclinical efficacy on GSK-3 inhibitors: towards a future generation of powerful drugs.
Martinez A
Med Res Rev; 2008 Sep; 28(5):773-96. PubMed ID: 18271054
[TBL] [Abstract][Full Text] [Related]
13. ER stress in cardiovascular disease.
Minamino T; Kitakaze M
J Mol Cell Cardiol; 2010 Jun; 48(6):1105-10. PubMed ID: 19913545
[TBL] [Abstract][Full Text] [Related]
14. Molecular mechanisms linking diabetes to the accelerated development of atherosclerosis.
Zeadin MG; Petlura CI; Werstuck GH
Can J Diabetes; 2013 Oct; 37(5):345-50. PubMed ID: 24500563
[TBL] [Abstract][Full Text] [Related]
15. [Molecular pathophysiology of late complications diabetes mellitus--hyperglycemia-induced changes].
Kanková K
Vnitr Lek; 2004 Oct; 50(10):756-67. PubMed ID: 15633931
[TBL] [Abstract][Full Text] [Related]
16. Evidence supporting a role for endoplasmic reticulum stress in the development of atherosclerosis in a hyperglycaemic mouse model.
Khan MI; Pichna BA; Shi Y; Bowes AJ; Werstuck GH
Antioxid Redox Signal; 2009 Sep; 11(9):2289-98. PubMed ID: 19548776
[TBL] [Abstract][Full Text] [Related]
17. Glucosamine-supplementation promotes endoplasmic reticulum stress, hepatic steatosis and accelerated atherogenesis in apoE-/- mice.
Beriault DR; Sharma S; Shi Y; Khan MI; Werstuck GH
Atherosclerosis; 2011 Nov; 219(1):134-40. PubMed ID: 21855875
[TBL] [Abstract][Full Text] [Related]
18. Glycogen synthase kinase 3 (GSK-3) inhibitors as new promising drugs for diabetes, neurodegeneration, cancer, and inflammation.
Martinez A; Castro A; Dorronsoro I; Alonso M
Med Res Rev; 2002 Jul; 22(4):373-84. PubMed ID: 12111750
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular risk factors in type 2 diabetes: the role of hyperglycaemia.
Massi-Benedetti M; Federici MO
Exp Clin Endocrinol Diabetes; 1999; 107 Suppl 4():S120-3. PubMed ID: 10522835
[TBL] [Abstract][Full Text] [Related]
20. Homocysteine metabolism in diabetes.
Wijekoon EP; Brosnan ME; Brosnan JT
Biochem Soc Trans; 2007 Nov; 35(Pt 5):1175-9. PubMed ID: 17956306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
